A carregar...
Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
Non‐alcoholic fatty liver disease (NAFLD) is strongly associated with obesity and may progress to non‐alcoholic steatohepatitis (NASH) and liver fibrosis. The deficit of pharmacological therapies for the latter mainly results from an incomplete understanding of involved pathological mechanisms. Here...
Na minha lista:
| Publicado no: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783644/ https://ncbi.nlm.nih.gov/pubmed/31595673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201810124 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|